With COVID-19 restrictions being eased in NSW, AllVascular is pleased to announce that as of last week, further patients have been implanted with the AVAS® to facilitate isolated and direct chemotherapy treatments. AllVascular is supporting the oncology and IR teams to accelerate the treatments for patients with secondary liver cancers.